14121-97-2

Basic information

• Product Name: Benzamide, 4-hydroxy-N-phenyl-
• CAS NO: 14121-97-2
• Molecular Formula: C13H11NO2
• Molecular Weight: 213.236
• Mol File: 14121-97-2.mol
• Article Data: 32

Chemical Properties

• CAS DataBase Reference: Benzamide, 4-hydroxy-N-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, 4-hydroxy-N-phenyl-(14121-97-2)
• EPA Substance Registry System: Benzamide, 4-hydroxy-N-phenyl-(14121-97-2)

Safety Data

• Hazardous Substances Data: 14121-97-2(Hazardous Substances Data)

Upstream product

• 4270-58-0 4-hydroxy-N-phenylbenzothioamide 
• 62-53-3 aniline 
• 501-97-3 4-hydroxyphenylpropionic acid 
• 201230-82-2 carbon monoxide 
• 540-38-5 p-Iodophenol 
• 591-50-4 iodobenzene 
• 619-57-8 p-hydroxybenzamide 
• 1137-42-4 4-Hydroxybenzophenone 
• 103-71-9 phenyl isocyanate 
• 108-95-2 phenol 
• 81123-44-6 (4-hydroxyphenyl)(phenyl)methanone oxime 
• 108-86-1 bromobenzene 
• 288-32-4 1H-imidazole 
• 79-37-8 oxalyl dichloride 

Downstream Products

• 124-38-9 carbon dioxide 
• 62-53-3 aniline 
• 108-95-2 phenol 
• 90446-66-5 2,6-bis(1-pyrrolidinylmethyl)-4-benzamidophenol 

Relevant articles and documents

Aryl alkyl ether compound as well as derivative, preparation method, pharmaceutical composition and application thereof

The invention discloses an aryl alkyl ether compound as well as a derivative, a preparation method, a pharmaceutical composition and application thereof. The structure of the aryl alkyl ether compound is shown as a formula (I). The aryl alkyl ether compound derivative relates to a stereoisomer, a tautomer, a metabolite, a metabolic precursor, a prodrug, a solvate, a salt of the solvate, a crystal, a pharmaceutically acceptable salt or a mixture of the stereoisomer, the tautomer, the metabolite, the metabolic precursor, the prodrug and the solvate of the aryl alkyl ether compound. The aryl alkyl ether compound and the derivative thereof have a remarkable inhibition effect on indoleamine 2, 3-dioxygenase 1, and can be used for preparing a medicine for treating indoleamine 2, 3-dioxygenase 1 mediated immunosuppression related diseases, and the prepared medicine can exert the medicine effect at the molecular level and is wide in application.

Lead Optimization and Structure-Activity Relationship Studies on Myeloid Ecotropic Viral Integration Site 1 Inhibitor

The pivotal role of the myeloid ecotropic viral integration site 1 (MEIS1) transcriptional factor was reported in cardiac regeneration and hematopoietic stem-cell (HSC) regulation with our previous findings. MEIS1 as a promising target in the context of p

Synthesis and characterization of Pd(II)–vitamin B6 complex supported on magnetic nanoparticle as an efficient and recyclable catalyst system for C–N cross coupling of amides in deep eutectic solvents

Vitamin B6–Pd(II) immobilized onto magnetic nanoparticles have been successfully prepared and applied for C–Xcross-coupling reactions with aryl halides in green deep eutectic solvents. The results prove that the Fe3O4@vitamin B6–Pd(II) magnetic nanoparticles show high catalyst activity and good stability. It was also revealed that this complex can be recycled up to five times without any significant loss in catalytic activity.